Invivyd Inc (IVVD)
2.21
-0.04
(-1.78%)
USD |
NASDAQ |
May 21, 16:00
2.21
0.00 (0.00%)
After-Hours: 20:00
Invivyd 1 Year Total Returns (Daily): 81.45% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 20, 2024 | 81.45% |
| May 17, 2024 | 57.89% |
| May 16, 2024 | 63.33% |
| May 15, 2024 | 60.78% |
| May 14, 2024 | 68.75% |
| May 13, 2024 | 64.58% |
| May 10, 2024 | 59.15% |
| May 09, 2024 | 103.4% |
| May 08, 2024 | 116.2% |
| May 07, 2024 | 110.9% |
| May 06, 2024 | 98.32% |
| May 03, 2024 | 106.8% |
| May 02, 2024 | 106.1% |
| May 01, 2024 | 95.16% |
| April 30, 2024 | 101.8% |
| April 29, 2024 | 89.09% |
| April 26, 2024 | 97.25% |
| April 25, 2024 | 86.49% |
| April 24, 2024 | 97.22% |
| April 23, 2024 | 97.39% |
| April 22, 2024 | 90.43% |
| April 19, 2024 | 69.12% |
| April 18, 2024 | 97.48% |
| April 17, 2024 | 115.7% |
| April 16, 2024 | 130.8% |
| Date | Value |
|---|---|
| April 15, 2024 | 140.2% |
| April 12, 2024 | 150.0% |
| April 11, 2024 | 153.5% |
| April 10, 2024 | 150.8% |
| April 09, 2024 | 141.6% |
| April 08, 2024 | 144.8% |
| April 05, 2024 | 177.3% |
| April 04, 2024 | 206.0% |
| April 03, 2024 | 244.7% |
| April 02, 2024 | 217.5% |
| April 01, 2024 | 254.2% |
| March 28, 2024 | 228.9% |
| March 27, 2024 | 186.7% |
| March 26, 2024 | 179.4% |
| March 25, 2024 | 146.6% |
| March 22, 2024 | 207.0% |
| March 21, 2024 | 96.82% |
| March 20, 2024 | 106.5% |
| March 19, 2024 | 119.2% |
| March 18, 2024 | 119.9% |
| March 15, 2024 | 123.6% |
| March 14, 2024 | 125.3% |
| March 13, 2024 | 117.1% |
| March 12, 2024 | 104.5% |
| March 11, 2024 | 110.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.35%
Minimum
Dec 05 2022
254.2%
Maximum
Apr 01 2024
-21.80%
Average
-60.68%
Median
Jun 07 2023
1 Year Total Returns (Daily) Benchmarks
| Vanda Pharmaceuticals Inc | -15.00% |
| Viking Therapeutics Inc | 193.9% |
| Stoke Therapeutics Inc | 43.49% |
| 180 Life Sciences Corp | -93.56% |
| MAIA Biotechnology Inc | 40.91% |